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Abstract
Purpose A cancer diagnosis and associated treatments are stressful experiences for most patients. Patients’ perceptions of stress
and their use of coping strategiesmay influence fatigue severity. This study extends our previous work describing distinct profiles
of morning (i.e., Very Low, Low, High, and Very High) and evening (i.e., Low, Moderate, High, and Very High) fatigue in
oncology patients by evaluating for differences in stress and coping strategies among these fatigue classes.
Methods This longitudinal study evaluated for changes in morning and evening fatigue in oncology patients (n = 1332) over two
cycles of chemotherapy (CTX). Patients completed measures of cumulative exposure to stressful life events (SLEs) (i.e., the Life
Stressor Checklist-Revised), general stress (i.e., Perceived Stress Scale [PSS]), cancer-specific stress (i.e., Impact of Event Scale-
Revised [IES-R]), and coping strategies (i.e., Brief Cope). Differences among the latent classes were evaluated using analyses of
variance, Kruskal-Wallis, or chi-square tests.
Results Patients in both the Very High morning and evening fatigue classes reported higher numbers of and a higher impact from
previous SLEs and higher PSS scores than the other fatigue classes. The IES-R scores for the Very High morning fatigue class
met the criterion for subsyndromal PTSD. Patients in the Very High evening fatigue class used a higher number of engagement
coping strategies compared with the Very High morning fatigue class.
Conclusions Our findings suggest that interventions to reduce stress and enhance copingwarrant investigation to decrease fatigue
in patients undergoing CTX.
Keywords Morning fatigue . Evening fatigue . Chemotherapy . Cumulative life stress . Coping . Stress . Cancer
Introduction
A cancer diagnosis and associated treatments are stressful
experiences for most patients [1]. Stress initiates a cascade
of pathways in the peripheral and central nervous systems
that activates the autonomic nervous system (ANS) and/or
the hypothalamic-pituitary-adrenal (HPA) axis to maintain
homeostasis [2]. Cognitive and emotional feedbacks from
the cortical and limbic areas of the brain modulate the
activity of hypothalamic and brain stem structures directly
controlling ANS and HPA activity [2, 3]. Fatigue is an
adaptive response to acute stress that conserves energy
and maintains homeostasis [3]. With repeated stressful
events or cumulative exposure to stressful life events
(SLEs), the ANS and HPA experience increased allostatic
load resulting in increased fatigue severity [4].
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Fatigue is the most common and debilitating symptom
experienced by oncology patients during chemotherapy
(CTX). Inter-individual variability in fatigue severity is
influenced by demographic, clinical, psychological, behav-
ioral, and biological characteristics [5]. In prior work [6,
7], we described four classes of oncology patients (N =
1332) with distinct profiles of morning and evening fatigue
severity, and demographic, clinical, and co-occurring
symptom characteristics that distinguished among these
classes. Using clinically meaningful cutoff scores for the
Lee Fatigue Scale (i.e., 3.2 for morning and 5.6 for eve-
ning), we labeled the four distinct morning (i.e., Very Low,
Low, High, and Very High) [6] and four distinct evening
(i.e., Low, Moderate, High, and Very High) [7] fatigue
profiles derived using latent profile analysis (LPA; see
Supplemental Figure 1).
Patients’ perceptions of stress and their use of coping
strategies may influence fatigue severity during CTX.
Differences in the perception and evaluation of external
events create variability in ANS and HPA activity levels,
resulting in variable levels of perceived stress [3] that may
influence inter-individual variability in fatigue severity.
While higher levels of perceived stress were associated
with greater fatigue severity [8–15], the majority of these
studies were cross-sectional and evaluated only women
with breast cancer [8–10, 13–15].
Coping encompasses a broad range of cognitive and
behavioral responses to stress to maintain homeostasis
[16]. Patients can use multiple coping strategies based on
their appraisal of the internal (e.g., acceptance) and exter-
nal (e.g., social support systems) resources available to
them to reduce, master, or tolerate stress [16]. In addition,
lifetime exposure to stressful experiences (e.g., physical or
sexual assault) and current life stressors (e.g., cancer diag-
nosis and treatment) influence coping [16]. Coping is often
described in terms of the use of engagement (e.g., actively
doing something to alter the stressor) or disengagement
(e.g., avoidance) strategies [16–18]. In the four studies that
examined the association between coping and fatigue dur-
ing CTX, greater fatigue severity was associated with dis-
engagement coping [19, 20], while lower fatigue severity
was associated with engagement coping [21, 22],
However, these studies did not examine the impact of cu-
mulative exposure to SLEs on coping and fatigue. One
study found that increased exposure to SLEs was associat-
ed with greater fatigue severity in women with breast can-
cer; however, the effects of coping were not evaluated [23].
Given the paucity of research on the relationships between
stress and coping and fatigue, the purpose of this study was
to evaluate for differences in cumulative exposure to SLEs,
general stress, cancer-specific stress, and coping strategies
among our previously identified morning [6] and evening
[7] fatigue classes.
Methods
Patients and settings
These analyses used data from a longitudinal study that eval-
uated the symptom experience of oncology patients receiving
CTX [24]. Written informed consent was obtained from
English literate patients ≥ 18 years of age who had received
one or two cycles of CTX for a diagnosis of breast, gastroin-
testinal, gynecological, or lung cancer within the 4 weeks pri-
or to enrollment and were scheduled for at least two additional
CTX cycles. Patients were recruited from seven different sites
that included community-based oncology programs and
Comprehensive Cancer Centers. Of the 2234 patients
approached, 1343 consented to participate (60.1% response
rate). Patients’ main reason for refusal was feeling
overwhelmed with their CTX treatment. Additional method-
ological details are described elsewhere [6, 7].
Instruments
Fatigue measures
The 18-item Lee Fatigue Scale (LFS) is designed to assess
physical fatigue and energy [25]. Each item was rated on a 0
to 10 numeric rating scale (NRS). Fatigue scores were calcu-
lated as the mean of the 13 fatigue items. Higher scores indi-
cate greater fatigue severity. Using separate LFS question-
naires, patients rated each item based on how they felt within
30 min of awakening (i.e., morning fatigue) and prior to going
to bed (i.e., evening fatigue). The LFS has established cutoff
scores for clinically meaningful levels of fatigue (i.e., ≥ 3.2 for
morning fatigue, ≥ 5.6 for evening fatigue) [26]. The LFS has
well-established validity and reliability and is easy to admin-
ister [25]. In our study, Cronbach’s alphas were 0.96 for morn-
ing and 0.93 for evening fatigue.
General stress measures
The Life Stressor Checklist-Revised (LSC-R) is a 30-item
inventory of lifetime exposure to stressful, potentially trau-
matic events (e.g., physical assault, death of a loved one)
[27]. The total LSC-R score was obtained by summing the
number of events endorsed (possible range is 0–30, with 30
indicating that the patient experienced all of the events). If the
patient endorsed an event, they indicated how much that
stressor affected their life in the past year, using a 1 (“not at
all”) to 5 (“extremely”) scale. These responses were averaged
to yield a mean “affected” score. The LSC-R has good to
moderate test-retest reliability and criterion-related validity
in diverse populations [28].
The 14-item Perceived Stress Scale (PSS) is a measure of
perceived stress according to the degree that life
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circumstances are appraised as stressful over the previous
4 weeks [29]. Each item was rated on a 0 (“never”) to 4 (“very
often”) scale. Total scores were summed after reversing the
seven positive items’ scores and can range from 0 to 56. A
higher score indicates greater stress. The PSS has well-
established validity and reliability [29]. In our study, its
Cronbach’s alpha was 0.85.
Cancer-specific stress measure
The 22-item Impact of Event Scale-Revised (IES-R) is used to
measure cancer-related stress [30]. Patients rated each item
based on how stressful each potential event was for them in
the past week on a 0 (not at all) to 4 (extremely) scale. Three
subscale (e.g., intrusion, avoidance, and hyperarousal) scores
and a total score were calculated [30]. The total score can
range from 0 to 88. A clinical cutoff score of 33 represents
probable post-traumatic stress disorder (PTSD), and scores of
≥ 37 suggest high levels of post-traumatic symptoms [30]. The
IES-R has well-established validity and reliability [30]. In this
sample, its Cronbach’s alpha was 0.91.
Coping strategy measure
The 28-item Brief Cope scale measures patients’ use of vari-
ous engagement and disengagement coping strategies [31].
For each strategy, patients rated the level of strategy use using
a 4-point Likert scale that ranged from 1 (“I haven’t been
doing this at all”) to 4 (“I have been doing this a lot”).
Higher scores indicate greater use of each coping strategy.
Fourteen total dimensions, represented by two items each,
were evaluated using this instrument (with their respective
Cronbach’s alphas): self-distraction (0.46), active coping
(0.75), denial (0.72), substance use (0.87), use of emotional
support (0.77), use of instrumental support (0.77), behavioral
disengagement (0.57), venting (0.65), positive reframing
(0.79), planning (0.74), humor (0.83), acceptance (0.68), reli-
gion (0.92), and self-blame (0.73). The Brief Cope has well-
established validity and reliability in oncology patients [32].
Study procedures
The study was approved by the Institutional Review Board at
each study site. A research team member approached eligible
patients during their first or second CTX cycle to discuss
participation and obtain written informed consent.
Depending on the length of their CTX cycle, patients com-
pleted the fatigue questionnaires in their homes, a total of six
times over two CTX cycles (i.e., before CTX administration,
approximately 1 week after CTX administration, approxi-
mately 2 weeks after CTX administration). Due to the poten-
tially sensitive nature of LSC-R items, patients were given
three options for its completion: in person with a research
team member, over the telephone, or on their own. Patients
were reminded that they could refuse to answer questions that
caused discomfort.
Data analysis
Data were analyzed using SPSS version 22 (IBM, Armonk,
NY). Descriptive statistics and frequency distributions were
calculated for the stress and coping measures. As previously
reported [6, 7], LPA was used to identify patient subgroups
with distinct morning or evening fatigue profiles over the six
assessments. We used the identified profiles in these analyses.
Differences in general and cancer-specific stress scores and
coping strategies scores among the classes were evaluated
using analyses of variance, Kruskal-Wallis, or chi-square tests
with Bonferroni-corrected post hoc contrasts (i.e., p < .008
[0.05/6]).
Results
Sample characteristics
In terms of differences in demographic and clinical character-
istics among the latent classes [6, 7], in brief, the overall sam-
ple was predominantly female, white, and college educated.
Compared with the other fatigue classes, patients in both the
Very High morning and evening fatigue classes were younger
and reported a higher comorbidity burden. Patients in the Very
High morning fatigue class were more likely to live alone and
had a higher body mass index. Patients in the Very High eve-
ning fatigue class were more likely to be female, have
childcare responsibilities, and have a lower functional status.
Morning fatigue
Differences in cumulative life stress and general stress
In terms of cumulative life stress, significant differences were
found among the morning fatigue classes for both the number
and impact of SLEs (Table 1). Compared with the Very Low
and Low classes (i.e., 5.2 and 5.4, respectively), patients in the
High and Very High classes reported a higher number of SLEs
(i.e., 6.4 and 8.5, respectively). An identical pattern of differ-
ences in the impact of SLEs was found among the morning
fatigue classes. Compared with the High class, patients in the
Very High class reported a higher number and a higher impact
of SLEs. In terms of general stress, across the four classes, as
the profiles of morning fatigue severity increased, PSS scores
increased (i.e., Very Low < Low < High < Very High;
Table 1).
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Differences in cancer-specific stress
For the intrusion and hyperarousal subscale and total scores of
the IES-R, the post hoc contrasts were significant in the fol-
lowing pattern: Very Low < Low < High < Very High. For the
avoidance subscale, compared with the Very Low class, pa-
tients in the Low, High, and Very High classes reported higher
scores (Table 1).
Differences in coping
Significant differences were found among the morning fa-
tigue classes in the frequency of use of eight of the fourteen
(57%) coping strategies (Table 2). Compared with the Very
Low class, patients in the Very High class were less likely
to use active coping and more likely to use denial.
Compared with the Very Low class, patients in the High
class were less likely to use acceptance. Compared with the
Low class, patients in the High class were more likely to
use instrumental support. Compared with the Very Low
class, patients in the Low, High, and Very High classes
were more likely to use self-distraction. Compared with
the Very Low class, patients in the High and Very High
classes were more likely to use behavioral disengagement.
Compared with the Very Low, Low, and High classes, pa-
tients in the Very High class were more likely to use
venting. Compared with the Very Low and Low classes,
patients in the High and Very High classes were more like-
ly to use self-blame. No significant differences were found
among the morning fatigue classes in the use of planning,
positive reframing, humor, religion, emotional support,
and substance use.
Evening fatigue
Differences in cumulative life stress and general stress
In terms of cumulative life stress, compared with the Low,
Moderate, and High classes, patients in the Very High class
reported a higher number of SLEs (i.e., 5.1, 5.9, 5.6, and
7.1, respectively; Table 1). In terms of the impact of SLEs,
compared with the Low, Moderate, and High classes, pa-
tients in the Very High class reported higher SLE impact
scores (i.e., 8.2, 12.0, 10.7, and 14.8, respectively;
Table 1). In addition, compared with the Low class, pa-
tients in the Moderate class reported higher SLE impact
scores. In terms of general stress, compared with the Low
class, patients in the other three evening fatigue classes
reported higher PSS scores. In addition, compared with
the Moderate and High classes, patients in the Very High
class reported higher PSS scores (Table 1).
Differences in cancer-specific stress
Compared with the Low class, patients in the Very High class
reported higher IES-R avoidance scores. Compared with the
Low class, patients in the Moderate, High, and Very High
classes reported higher intrusion, hyperarousal, and IES-R
total scores. In addition, compared with the Moderate and
High classes, patients in the Very High class reported higher
intrusion, hyperarousal, and IES-R total scores (Table 1).
Differences in coping
Significant differences were found among the evening fatigue
classes in the frequency of use of eight of the fourteen (57%)
coping strategies (Table 2). Compared with patients in the
other three classes, patients in the Very High class were more
likely to use planning, emotional support, instrumental sup-
port, and self-blame. Compared with the Low class, patients in
the High and Very High classes were more likely to use humor
and self-distraction. Compared with the High and Very High
classes, patients in the Moderate class were more likely to use
religion. Compared with the Low and Moderate classes, pa-
tients in the High and Very High classes were more likely to
use venting. Compared with the other three classes, patients in
the Very High class were more likely to use self-blame. No
significant differences were found among the evening fatigue
classes in the use of active coping, positive reframing, accep-
tance, denial, substance use, and behavioral disengagement.
Discussion
This study extends our previous work identifying patients
with morning [6] and evening [7] fatigue profiles to include
associations with cumulative life stress, cancer-specific stress,
and coping. While previous research found associations be-
tween childhood SLEs and increased risk for greater fatigue
severity in women with breast cancer [8], our study is the first
to evaluate the impact of SLEs on fatigue severity in a sample
of patients with heterogeneous cancer diagnoses. Compared
with the other three classes, patients in both the Very High
morning and evening fatigue classes reported higher numbers
of and higher impact from previous SLEs. The increased
allostatic load associated with cumulative SLEs [4] is a plau-
sible explanation for these associations. For example, higher
levels of and higher impact from SLEs increased the risk of
experiencing chronic pain [33], as well as fatigue and depres-
sion [34]. These findings suggest that SLEs in oncology pa-
tients may be associated with increased risk for multiple co-
occurring symptoms and warrant further study.
Given that higher cumulative life stress was associatedwith
increased allostatic load in healthy adults and in patients with
irritable bowel syndrome [35], our findings of higher PSS
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scores in the Very High morning and evening fatigue classes,
compared with the other classes, suggests that this mechanism
may occur in oncology patients. Equally important, PSS
scores were associated with greater fatigue severity in adults
with rheumatoid arthritis, fibromyalgia, and inflammatory
bowel disease [36] and unexplained chronic fatigue [37].
Because these conditions and fatigue associated with cancer
share inflammation as a common underlying mechanism, fu-
ture studies need to examine the additive or synergistic effects
of stress and inflammatory mechanisms on fatigue severity.
A cancer diagnosis and its treatment(s) are significant
stressors, with 20% of patients reporting cancer-related
subsyndromal PTSD [1]. The IES-R total score for patients
in the Very High morning fatigue class (i.e., 29.9) meets the
criterion for subsyndromal PTSD [30]. This finding is consis-
tent with previous reports of greater fatigue severity being
associated with higher IES-R total scores in patients with
Cushing’s disease [38] and survivors of Middle East respira-
tory syndrome [39]. While the patients in the Very High
evening fatigue class had IES-R total scores below the clini-
cally meaningful cutoff for subsyndromal PTSD (i.e., IES-R
total score of 21.7), their scores were significantly higher than
those of the other three evening fatigue classes, which sug-
gests that cancer-specific stress is a risk factor for greater eve-
ning fatigue severity. Given the negative impact of fatigue on
oncology patients receiving CTX [40], the higher scores on
the avoidance, intrusion, and hyperarousal subscales of the
IES-R are not unexpected. Our findings suggest that interven-
tions to decrease cancer-specific stress (e.g., yoga [41]) may
decrease fatigue severity.
In terms of the impact of coping strategies on fatigue, in
older oncology patients (i.e., > 70 years), disengagement cop-
ing strategies were associated with higher fatigue severity
[42]. In contrast, engagement coping strategies mediated fa-
tigue’s impact during [42] and after [42, 43] cancer treatment
completion. In studies that explored the perceptions of effec-
tive coping strategies for fatigue in patients with chronic ob-
structive pulmonary disease [43] and end-stage kidney disease
Table 3 Comparison of the stress
measures and coping strategies
associated with membership in
the highest morning and evening
fatigue classes compared with the
lowest morning and evening
fatigue classes
Characteristics Very High morning fatigue Very High evening fatigue
Stress measures
LSC-R—number of SLEs ↑ ↑
LSC-R—impact of SLEs ↑ ↑
Perceived Stress Scale ↑ ↑
IES-R—avoidance ↑ ↑
IES-R—intrusion ↑ ↑
IES-R—hyperarousal ↑ ↑
IES-R—total score ↑ ↑
Coping strategies
Engagement
Active coping ↓
Planning ↑
Using emotional support ↑
Using instrumental support ↑
Disengagement
Avoidance ↑
Denial ↑
Self-blame ↑ ↑
Emotion-based
Venting ↑ ↑
Other subscales
Self-distraction ↑ ↑
Humor ↑
Religion ↓
↑ =Higher score for the highest morning and evening fatigue classes compared with the lowest classes
↓ = Lower score for the highest morning and evening fatigue classes compared with the lowest classes
IES-R, Impact of Event Scale-Revised; LSC-R, Life Stressor Checklist-Revised; SLEs, stressful life events
The coping strategies of positive reframing, acceptance, religion, and substance use are not included in the table
because no significant differences were found between the highest morning and evening fatigue latent classes
compared with the lowest classes
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(ESKD) [44], both groups valued clinicians’ acknowledgment
of fatigue variability, support to deal with the impact of fatigue
in their daily lives, and active participation in individualizing
interventions [43, 44].
Noticeable similarities and differences were apparent in the
coping strategies used by patients in the Very High morning
and Very High evening fatigue classes (Table 3). Patients in
the Very High evening fatigue class identified using engage-
ment coping strategies more frequently than patients in the
Very High morning fatigue class. One possible explanation
for this difference in the use of engagement coping strategies
may be the impact of morning compared with evening fatigue.
In healthy adults, awakening refreshed without fatigue is con-
sidered “normal” [45]. Therefore, a patient may not actively
plan or seek support when they expect to feel less fatigued in
the morning. Educating patients about diurnal variability in
fatigue and its potential impact on daily activities may in-
crease the use of engagement coping strategies.
The finding that both the Very High morning and evening
fatigue groups used self-blame as a coping strategy is consis-
tent with prior research that identified self-blame as a predictor
of fatigue in new parents [46], as well as in patients with
melanoma [47], multiple sclerosis [48], and breast cancer
[49]. In contrast, self-compassion was identified by patients
with ESKD as an effective intervention to decrease their self-
blame when they needed to ask for support to cope with their
fatigue [44]. Teaching self-compassion may support patients
to use more engaged coping behaviors for their stress and
fatigue.
As an emotion-based coping strategy, venting refers to fo-
cusing on and expressing negative feelings [17]. While not
evaluated in oncology patients, venting was found to increase
patients’ ability to cope with both positive and negative feel-
ings about multiple sclerosis [48] and may warrant evaluation
as a strategy for fatigue.
Our finding that patients in both the Very High morning
and evening fatigue classes used self-distraction to cope with
fatigue is not unexpected. Self-distraction was identified as an
effective coping strategy for fatigue in oncology patients dur-
ing CTX [20], in patients with ESKD [44], and in healthy
working adults [50]. Self-distraction may be used to shift the
focus from fatigue without eliminating or treating the symp-
tom [50].
While using humor as a coping strategy was associated
with decreased stress in women with breast cancer [51], it
was not associated with decreased fatigue severity [49]. In
general, humor is a personal experience, used in different
ways and situations based on culture and gender [52].
Therefore, it is possible that the patients’ personalities in the
Very High evening fatigue class may have influenced their use
of humor. The influence of personality characteristics on the
use of various coping strategies to decrease fatigue warrants
additional investigation.
Religion and spirituality have distinct and overlapping con-
structs [53]. The religion subscale of the Brief Cope assesses
several of these overlapping constructs (e.g., using prayer or
meditation) [31]. In oncology patients, spiritual well-being
was associated with lower fatigue severity [54]. However,
religious/spiritual coping support is not a consistent part of
patient care [53]. Assessing patients’ interest in the use of
religious/spiritual coping strategies and providing support
for these strategies may assist with fatigue management.
Further research on the association between fatigue and
religious/spiritual coping strategies is warranted.
Study limitations should be acknowledged. Patients were
recruited at various times during their cancer treatment.
Therefore, cancer-specific stress at diagnosis was not evaluat-
ed. Because the LSC-R is a retrospective evaluation, it is pos-
sible that the patients’ current symptom experiences or cancer
diagnosis and treatment influenced their memories of past
events. While the subjective measures of stress are valid and
reliable, future studies should examine associations between
the severity of morning and evening fatigue and objective
measures of stress (e.g., hair cortisol) as well as inflammatory
genes and their expression and regulation. In addition, future
studies should examine the extreme fatigue classes (i.e., Very
Low morning versus Low evening, and Very High morning
versus Very High evening) for differences in stress and coping
strategies.
Despite these limitations, this longitudinal study with a
large representative sample of oncology patients is the first
to evaluate for associations among SLEs, general stress,
cancer-specific stress, and the use various coping strategies
and greater morning and evening fatigue severity during
CTX. In addition, prior research has identified that higher
levels of SLEs may decrease a patient’s participation in
health-related behaviors (e.g., physical activity) [55], which
may affect adherence to exercise interventions prescribed to
decrease fatigue severity. Additional studies are needed that
evaluate the effect of stress management strategies and inter-
ventions targeted at the use of disengagement coping strate-
gies to mitigate morning and evening fatigue.
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